By characterizing for the first time the APL metabolic background, we demonstrate that PML::RARα inhibits glycolysis via AKT degradation, promotes TCA, and favors LCFA catabolism, exposing APL cells to strong dependency and vulnerabilities to OXPHOS inhibition. Here, AKT1 is linked to acute promyelocytic leukemia.